On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayJul 20, 2017 11:45 am

NetworkNewsAudio – Lexaria Bioscience Corp. (OTCQB: LXRP) Interview

About Lexaria Bioscience Corp. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products. View Complete Profile

Continue Reading

FridayJul 07, 2017 1:31 pm

NetworkNewsAudio – Patriot One Technologies, Inc. (OTCQB: PTOTF) Interview

About Medical Transcription Billing, Corp. Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology. Developed through a NATO-funded project at McMaster University, Patriot One’s disruptive NForce CMR1000 (PATSCAN) technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide. View Complete Profile

Continue Reading

WednesdayJun 07, 2017 8:59 am

NetworkNewsAudio – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Interview

About BriaCell Therapeutics Corp. BriaCell is an immuno-oncology-focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell is currently conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a combination study with pembrolizumab [Keytruda; manufactured by Merck & Co., Inc.] or ipilimumab [Yervoy; manufactured by Bristol-Myers Squibb Company]. The combination study is listed in ClinicalTrials.gov as NCT03328026. BriaCell is developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS, which is expected to cover over 90 percent…

Continue Reading

ThursdayFeb 09, 2017 2:24 pm

NetworkNewsAudio – Singlepoint, Inc. (SING) Interview

Singlepoint, Inc. (SING) SING provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. View Complete Profile

Continue Reading

ThursdayFeb 02, 2017 2:31 pm

NetworkNewsAudio – Stealth Technologies, Inc. (STTH) Interview

Stealth Technologies, Inc. STTH is focused on cost effective, independently validated solutions for large addressable international and domestic markets, with its primary target being identity protection and personal safety, via offerings like its Stealth Card identity theft device. View Complete Profile

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217